You are viewing: China Biosurgery Market analysis
Part of: Biosurgery Market (Global)

The China Biosurgery Market was valued at $2597.6 Million in 2025 and projected to reach to $3833 Million by 2030, representing a compound annual growth rate of 8.1%. China's biosurgery market is positioned for accelerated growth through 2030, supported by expanding healthcare access in tier-2 and tier-3 cities and increasing adoption of advanced surgical techniques.

China Biosurgery Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Biosurgery Market Trends and Insights

  • This accelerated growth in China significantly outpaces the global biosurgery market CAGR of 6.4%, reflecting the country's rising healthcare investments and surgical procedure volumes.
  • China's aging population, increasing prevalence of chronic diseases, and expanding access to advanced surgical technologies are driving demand for hemostatic agents, tissue sealants, and regenerative medicine products. The biosurgery sector in China is benefiting from government healthcare reforms, improved reimbursement policies, and growing adoption of minimally invasive surgical techniques across hospitals and surgical centers.
  • China's market growth is further supported by domestic manufacturing capabilities and rising investments in medical device innovation.
  • Between 2025 and 2030, China is expected to consolidate its position as a key growth engine within the Asia Pacific biosurgery market, driven by urbanization, enhanced surgical infrastructure, and increasing patient awareness of advanced treatment options..

Key Market Statistics

  • CAGR (2025-2030) 8.1% CAGR
  • Market Size, 2025 ~USD 2597.6 Million
  • Forecast, 2030 ~USD 3833 Million
  • Country China

China Biosurgery Market Overview

Fastest Growing Market Globally :

China's biosurgery market CAGR of 8.1% significantly outpaces the global average of 6.4%, driven by increasing surgical volumes and healthcare modernization across the country.

Substantial Market Valuation :

The Chinese biosurgery market is valued at USD 2,597.6 million in 2025, with projected growth to USD 3,833.0 million by 2030, representing a USD 1,235.4 million market expansion opportunity.

Rising Healthcare Investments :

China's commitment to healthcare infrastructure development and increased government spending on surgical capabilities are fueling demand for advanced biosurgical products and solutions.

Aging Population Dynamics :

China's rapidly aging demographic profile is driving higher surgical procedure volumes, creating sustained demand for biosurgical products across orthopedic, cardiovascular, and general surgery segments.

China Biosurgery Market Dynamics

  • Government initiatives promoting medical device innovation and healthcare quality improvements are creating favorable conditions for market expansion.
  • The country's focus on reducing surgical complications and improving patient outcomes is driving hospital procurement of premium biosurgical products.
  • Additionally, rising disposable incomes and growing awareness of advanced treatment options among Chinese consumers are expected to sustain robust market momentum.
  • Strategic partnerships between international manufacturers and local distributors will further enhance market penetration and accessibility across China's diverse healthcare landscape..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's biosurgery market is valued at USD 2,597.6 million in 2025 and is forecast to grow to USD 3,833.0 million by 2030 at an 8.1% CAGR.
    • China's biosurgery growth rate of 8.1% significantly exceeds the global market CAGR of 6.4%, positioning China as a high-growth market within Asia Pacific.
    • Government healthcare reforms, improved reimbursement policies, and rising surgical procedure volumes are key drivers accelerating biosurgery adoption across China.
    • China's aging population and increasing prevalence of chronic diseases are expanding demand for hemostatic agents, tissue sealants, and regenerative medicine solutions.

    Biosurgery Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment BONE MORPHOGENETIC PROTEINS (Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 6.4% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 15.83 (2025)
    Revenue Forecast (Billions) ~USD 21.59 (2030)
    Segments Covered Type, Origin, Application, End User, Product

    China Biosurgery Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Type

    • Albumin-Based Sealants & Adhesives
    • Allografts
    • Biological Meshes
    • Bone Morphogenetic Proteins
    • Collagen & Protein Adhesion Barriers
    • Collagen-Based Sealants & Adhesives
    • Combination Hemostatic Agents
    • Cyanoacrylate-Based Sealants & Adhesives
    • Demineralized Bone Matrix
    • Fibrin-Based Adhesion Barriers
    • Fibrin-Based Sealants & Adhesives
    • Gelatin-Based Sealants & Adhesives
    • Hyaluronic Acid-Based Adhesion Barriers
    • Natural Adhesion Barriers
    • Natural/Biological Sealants & Adhesives
    • Natural/Biological Surgical Sealants & Adhesives
    • Other Bone-Graft Substitutes
    • Other Natural/Biological Surgical Sealants & Adhesives
    • Other Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Other Synthetic Adhesion Barriers
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Peg Hydrogel-Based Sealants & Adhesives
    • Peg-Based Adhesion Barriers
    • Regenerated Cellulose-Based Adhesion Barriers
    • Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Synthetic Adhesion Barriers
    • Synthetic Bone Grafts
    • Synthetic Meshes
    • Thrombin-Based Hemostatic Agents
    • Urethane-Based Sealants & Adhesives
    • Xenografts

    By Origin

    • Animal-Based Sealants & Adhesives
    • Human Blood-Based Sealants & Adhesives

    By Application

    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Other Applications
    • Reconstructive Surgery
    • Thoracic Surgery
    • Urological Surgery

    By End User

    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Other End Users

    By Product

    • Adhesion Barriers
    • Bone-Graft Substitutes
    • Hemostatic Agents
    • Soft-Tissue Attachments
    • Staple-Line Reinforcement Agents
    • Surgical Sealants & Adhesives

    Target Audience

    • Medical Device Manufacturers : Biosurgical product companies need China-specific market data to evaluate market entry feasibility, competitive positioning, and revenue forecasting for strategic expansion decisions.
    • Healthcare Investors & PE Firms : Investment professionals require validated China market metrics and growth projections to assess portfolio opportunities and identify high-potential biosurgery companies targeting Chinese expansion.
    • Hospital & Healthcare Systems : Chinese hospital networks and healthcare administrators need market intelligence to inform procurement strategies, supplier selection, and budget allocation for biosurgical products.
    • Distributors & Importers : Medical device distributors operating in China require market sizing and segment analysis to optimize inventory, negotiate supplier terms, and identify emerging growth opportunities.
    • Market Consultants & Analysts : Healthcare consultants and research professionals need authoritative China biosurgery data to support client advisory work, competitive analysis, and strategic recommendations.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for China (USD 2,597.6M in 2025) and verified 5-year forecasts to support investment decisions and business planning in Asia's largest healthcare market.
    • Competitive Intelligence : Understand China-specific market dynamics, competitive positioning, and growth drivers that differentiate this market from global trends, enabling targeted go-to-market strategies.
    • Regulatory & Market Access Insights : Access China-specific regulatory requirements, reimbursement landscapes, and healthcare system nuances critical for product launches and market entry planning.
    • Segment & Application Analysis : Identify high-growth biosurgery segments within China (orthopedic, cardiovascular, general surgery) to prioritize product development and commercial resource allocation.
    • Strategic Partnership Opportunities : Leverage detailed China market intelligence to identify distribution partners, hospital networks, and collaboration opportunities aligned with the country's 8.1% CAGR expansion trajectory.

    Frequently asked questions

    What is the current size of China's biosurgery market in 2025?

    China's biosurgery market is valued at USD 2,597.6 million in 2025, reflecting strong demand for surgical hemostats, tissue sealants, and regenerative medicine products.

    What is the projected size of China's biosurgery market by 2030?

    China's biosurgery market is projected to reach USD 3,833.0 million by 2030, growing at a compound annual growth rate of 8.1% from 2025 to 2030.

    How does China's biosurgery market growth compare to global trends?

    China's biosurgery market CAGR of 8.1% significantly outpaces the global market CAGR of 6.4%, making China one of the fastest-growing biosurgery markets globally.

    What are the primary drivers of biosurgery market growth in China?

    Key growth drivers in China include an aging population, rising prevalence of chronic diseases, government healthcare reforms, improved reimbursement policies, and increased adoption of minimally invasive surgical techniques.

    Which biosurgery products are most in demand in China?

    Hemostatic agents, tissue sealants, and regenerative medicine products are experiencing strong demand in China due to expanding surgical volumes and improved access to advanced surgical technologies.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Biosurgery Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various biosurgery manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from biosurgery (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global biosurgery market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach and Top-down Approach)

    Biosurgery Market

    Data Triangulation

    After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.

    Stakeholders

    • Transfection products manufacturing companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Chemical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Development and Manufacturing Organizations (CDMOs)
    • Research Institutes and Universities 
    • Venture Capitalists & Investors
    • Government Associations

    Report Objectives

    • To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
    • To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
    • To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
    • To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
    • To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

    Get the Full Biosurgery Market Report

    Full forecast, segment splits, and company analysis for all Biosurgery Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status